![]() |
JOURNAL TOOLS |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |

YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS NEW DEVELOPMENT IN SFA STENTING
The Journal of Cardiovascular Surgery 2013 August;54(4):455-67
Copyright © 2013 EDIZIONI MINERVA MEDICA
language: English
Treating with an implant: BMS or DES?
Marques L., Preiss M., Preuss H., Hopf-Jensen S., Mueller-Huelsbeck S. ✉
Institute for Diagnostic and Interventional Radiology/Neuroradiology, Flensburg, Germany
As the minimal invasive procedures for the treatment of peripheral arterial disease grow at exponential rates, interventional radiologists and vascular surgeons are more often faced with the difficult decision of which devices are the most appropriate to bring the desired results. Under the light of the newest studies and always having in mind the concept of “leaving no metal behind”, when focusing on the lesions within the superficial femoral artery and popliteal arteries, we try to answer the question: treating with an implant, bare metal stents or drug eluting stents?